Company / FCF Margin
GeneDx Holdings Corp. FCF Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
3.3%
FY2025
5-year range
-139.0% / 3.3%
FY2021-FY2025
Trend
+130.0%
vs FY2024
Sector context
#91 of 139
Health Care
What the data says
At 3.3%, GeneDx Holdings Corp.'s fcf margin ranks #91 of 139 in the Health Care sector. FCF Margin has increased for 3 consecutive years, from -139.0% in FY2022 to 3.3% in FY2025.
Based on SEC 10-K filings.
3.3% in FY2025 with a 3-year CAGR of +142.4%.
Improved from -91.5% to 3.3% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +142.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#91 of 139 in Health CareTop 65% of 139This company 3.3% Sector average -217.0%
▼
+101.5% above sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s fcf margin has grown for 3 consecutive years.
- In FY2025, fcf margin increased 130.0% year-over-year.
- Currently 220.3pp above the Health Care sector average.
- Lowest fcf margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 3.3% | +130.0% |
| FY2024 | -11.1% | +87.8% |
| FY2023 | -91.5% | +34.2% |
| FY2022 | -139.0% | -47.6% |
| FY2021 | -94.2% | - |
| FY2020 | - | - |
| FY2019 | -15.6% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026